Navigation Links
Peter MacCallum Cancer Centre Expands Cancer Research Efforts with Automation Tool from Caliper Life Sciences
Date:5/19/2009

- Foundation Purchases Caliper's Staccato System to Enable High Throughput Research Processes -

HOPKINTON, Mass., May 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced a collaboration with the Peter MacCallum Cancer Centre (PMCC), based in Melbourne, Victoria, Australia. PMCC is using Caliper's Staccato automation system to perform oncology related lab discovery experiments in less time, leading to a better understanding of how to treat and prevent cancer through gene knockdown therapies.

"We would be unable to perform this type of large scale research without the Staccato workstation from Caliper," said Dr. Kaylene Simpson, manager of the Functional Genomics Group at PMCC. "The instrument helps us work towards our primary goals: to identify genes that regulate cancer cell growth, survival, and proliferation, and responses to drug targets."

The Functional Genomics Group at PMCC is funded by the Australian Cancer Research Foundation (ACRF) and provides Australian research institutes with access to large scale, high throughput gene knockdown technology that aids cancer research. By eliminating a gene's ability to express, gene knockdown techniques may uncover ways to silence specific genes associated with cancer, leading to new forms of treatment. Researchers at PMCC are currently working with the Dharmacon entire human and mouse genome collections (~21,000 genes), attempting to knockdown each one. The Staccato enables the researcher to work through these gene sets in a rapid, systematic and reproducible way.

"The Peter MacCallum Cancer Centre's decision to rely on the Staccato reinforces Caliper's position as a leading provider of automation solutions for the life sciences industry," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "Caliper has made significant strides in helping our customers with oncology research. From automation to imaging and tumor models, Caliper provides researchers with the tools to conduct quality oncology research."

Led by Richard Holder, Millennium Science, a distributor of instrumentation and reagents for the biotechnology research and industrial markets, has been a Caliper partner and distributor for 12 years. Millennium worked closely with the PMCC and has been responsible for driving awareness and usage of the Staccato system in Australia.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper and Staccato are registered trademarks of Caliper Life Sciences, Inc.

About Peter MacCallum Cancer Centre

In the midst of a worldwide effort, the Peter MacCallum Cancer Centre is in a powerful position to help in the war on cancer. It is one of a handful of comprehensive cancer centres outside the United States and houses the largest cancer research group in Australia, with over 500 staff across the Centre involved in cancer research. The combination of a specialist cancer hospital and an embedded sophisticated laboratory complex provides unparalleled opportunities to inform clinical practice and engage in translational clinical research.

To be most effective, cancer research at Peter Mac has been structured in the form of multidisciplinary teams of laboratory scientists, clinician-researchers and allied health staff. Our spectrum of research ranges from laboratory-based studies into the fundamental mechanisms of cell growth, translational studies that seek more accurate cancer diagnosis, clinical trials with novel treatments, to research aimed at improving our supportive care of patients.

For more information about research at Peter Mac please visit www.petermac-research.org.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. St. Petersburg: Candlelight Vigil to Raise Awareness of Florida HIV/AIDS Crisis, Honor Lives Lost
2. Shameful Votes Today on Childrens Health Care by Reps. John Peterson, Joe Pitts and Bill Shuster
3. Mayo Clinics Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
4. Dr. Peter B. Corr Joins Team at Celtic Therapeutics as General Partner
5. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
6. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
7. Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Childrens Health Care
8. Noted Litigator Peter Diedrich Joins Musick Peeler & Garrett LLP
9. Dr. Peter Covitz Joins MDS Nordion as Senior Vice-President Innovation
10. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
11. Peter G. Peterson Commits $1 Billion Toward Solving Americas Most Significant Economic Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
Breaking Medicine Technology: